Effects of ginger (Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients

International Journal of Food Sciences and Nutrition

Volumn 64, Issue 6, 2013, Pages 682-686

  Mahluji, Sepide ^a   Attari, Vahide Ebrahimzade ^a   Mobasseri, Majid ^b   Payahoo, Laleh ^a   Ostadrahimi, Alireza ^c   Golzari, Samad EJ ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Blood glucose; Diabetes; Ginger; Insulin sensitivity

Indexed keywords

EID: 84881344632     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2013.775223     Document Type: Article

References (32)

1. Akhani S, Vishwakarma S, Goyal R. 2005. Antidiabetic activity of Zingiber officinale roscoe in streptozotocin-induced non-insulin dependent diabetic rats. Indian J Pharm Sci 67:553-7.
2. Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R, Ali M. 2006. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Brit J Nutr 96: 660-6.
3. Ali BH, Blunden G, Tanira MO, Nemmar A. 2008. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research. Food Chem Toxicol 46:409-20.
4. Alizadeh-Navaei R, Roozbeh F, Saravi M, Pouramir M, Jalali F, Moghadamnia AA. 2008. Investigation of the effect of ginger on the lipid levels: A double blind controlled clinical trial. Saudi Med J 29: 1280-4.
5. Altman RD, Marcussen KC. 2001. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 44:2531-8.
6. Bhandari U, Pillai KK. 2005. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol 97: 227-30.
7. Borai A, Livingstone C, Ferns GAA. 2007. The biochemical assessment of insulin resistance. Ann Clin Biochem 44:324-42.
8. Bordia A, Verma S, Srivastava K. 1997. Effect of ginger (Zingiber officinale Rosc) and fenugreek (Trigonella foenumgraecum L) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostag Leukotrienes Essential Fatty Acids 56:379-84.
9. Bryer E. 2005. A literature review of the effectiveness of ginger in alleviating mild-to-moderate nausea and vomiting of pregnancy. J Midwifery Women's Health 50:e1-3.
10. Desai H, Kalro R, Choksi A. 1990. Effect of ginger and garlic on DNA content of gastric aspirate. Indian J Med Res 92:139-41.
11. Elshater AE, Salman MA, Moussa MA. 2009. Effect of ginger extract consumption on levels of blood glucose, lipid profile and kidney functions in alloxan induced-diabetic rats. Egypt Acad J Biol Sci 2: 153-62.
12. Goyal RK, Kadnur SV. 2006. Beneficial effects of Zingiber officinale on goldthioglucose induced obesity. Fitoterapia 77:160-3.
13. Henriksen EJ. 2006. Exercise training and the antioxidant [alpha]-lipoic acid in the treatment of insulin resistance and type 2 diabetes. Free Radical Biol Med 40:3-12.
14. Kamenova P. 2006. Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid. Hormones (Athens, Greece) 5:251-8.
15. Kato A, Higuchi Y, Goto H, Kizu H, Okamoto T, Asano N, Hollinshead J, et al. 2006. Inhibitory effects of Zingiber officinale Roscoe derived components on aldose reductase activity in vitro and in vivo. J Agric Food Chem 54:6640-4.
16. Kavishankar G, Lakshmidevi N, Murthy SM, Prakash H, Niranjana S. 2011. Diabetes and medicinal plants-a review. Int J Pharm 2:65-80.
17. Lien HC, Sun WM, Chen YH, Kim H, Hasler W, Owyang C. 2003. Effects of ginger on motion sickness and gastric slow-wave dysrhythmias induced by circular vection. Am J Physiol Gastrointestinal Liver Physiol 284:G481-9.
18. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. 1985. Homeostasis model assessment: Insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-19.
19. Mustafa T, Srivastava K. 1990. Ginger (Zingiber officinale) in migraine headache. J Ethnopharmacol 29:267-73.
20. O'Rahilly S, Gray H, Hattersley A, Vaag A. 1994. Insulin resistance as the major cause of impaired glucose tolerance: A self-fulfilling prophesy? Lancet 344:585-9.
21. Ozougwu J, Eyo J. 2011. Evaluation of the activity of Zingiber officinale (ginger) aqueous extracts on alloxan-induced diabetic rats. Pharmacologyonline 1:258-69.
22. Pei L, Lin-Yun D, Zhan-Ke W, Ping W, Xiao-Li D. 2007. Effects of insulin resistance on vascular endothelial function in type 2 diabetes mellitus. Acta Acad Med Jiangxi 6:252-6.
23. Pistrosch F, Passauer J, Fischer S, Fuecker K, Hanefeld M, Gross P. 2004. In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control. Diabetes Care 27:484-90.
24. Sekiya K, Ohtani A, Kusano S. 2004. Enhancement of insulin sensitivity in adipocytes by ginger. Biofactors 22:153-6.
25. Shanmugam KR, Mallikarjuna K, Nishanth K, Kuo CH, Reddy KS. 2011. Protective effect of dietary ginger on antioxidant enzymes and oxidative damage in experimental diabetic rat tissues. Food Chemy 124:1436-42.
26. Shukla Y, Singh M. 2007. Cancer preventive properties of ginger: A brief review. Food Chem Toxicol 45:683-90.
27. Singhal PC, Joshi LD. 1983. Glycaemic and cholesterolemic role of ginger and till. J Sci Res Plants Med 4:32-4.
28. Srivastava K, Mustafa T. 1992. Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Medical Hypotheses 39:342-8.
29. Turner R, Holman R, Cull C, Stratton I, Matthews D, Frighi V, Manley S, et al. 1998. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-53.
30. Vuksan V, Whitham D, Sievenpiper JL, Jenkins AL, Rogovik AL, Bazinet RP, Vidgen E, Hanna A. 2007. Supplementation of conventional therapy with the novel grain salba (Salvia hispanica L) improves major and emerging cardiovascular risk factors in type 2 diabetes. Diabetes Care 30:2804-10.
31. White B. 2007. Ginger: An overview. Am Fam Physician 75:1689-91.
32. Zar JH. 1999. Biostatistical analysis. New Jersey: Prentice Hall.